fda warning letter compounding semaglutide october 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 Three Considerations When Prescribing Compounded

Pill press news in Florida and Mississippi

P.MaratheC

Anne Nissen, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark

That's a genuinely significant development in obesity medicine, and it's the reason GLP-1 therapy has moved from "cosmetic weight loss medication" to "cardiometabolic treatment" in clinical guidelines

The most pronounced effects were observed in glial cells, the metabolic and inflammatory support system of the brain, suggesting that improving the brains environment may be as important as targeting neurons directly